Treatment of pediatric chronic pain with tramadol hydrochloride: Siblings with Ehlers-Danlos syndrome - Hypermobility type

Pain Research and Management

Volumn 9, Issue 4, 2004, Pages 209-211

  Brown, Stephen C ^a   Stinson, Jennifer ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chronic pain; Ehlers Danlos syndrome; Pediatrics; Tramadol

Indexed keywords

BECLOMETASONE DIPROPIONATE; CODEINE; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; HYDROCODONE BITARTRATE; IBUPROFEN; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; PANTOPRAZOLE; PARACETAMOL; ROFECOXIB; SALBUTAMOL; SALMETEROL XINAFOATE; SULFONAMIDE; TRAMADOL;

ANALGESIA; ARTICLE; ASTHMA; CASE REPORT; CHILD; CHILDHOOD DISEASE; CHRONIC PAIN; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EDEMA; EHLERS DANLOS SYNDROME; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; JOINT HYPERMOBILITY; MALE; MORBIDITY; PAIN ASSESSMENT; PHARYNX DISEASE; PHYSICAL ACTIVITY; SIBLING; SIDE EFFECT; URTICARIA;

EID: 12144272580     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/370915     Document Type: Article

References (11)

1. Sacheti A, Szemere J, Bernstein B, Tafas T, Schechter N, Tsipouras P. Chronic pain is a manifestation of the Ehlers-Danlos syndrome. J Pain Symptom Manage 1997;14:88-93.
2. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31-7.
3. Berglund B, Nordstrom G, Lutzen K. Living a restricted life with Ehlers-Danlos Syndrome (EDS). Int J Nurs Stud 2000;37:111-8.
4. Iurassich S, Rocco D, Aurilia A. Type III Ehlers-Danlos syndrome: Correlations among clinical signs, ultrasound and histologic findings in a study of 35 cases. Int J Dermatol 2001;40:175-8.
5. Burrows NP. The molecular genetics of the Ehlers-Danlos syndrome. Clin Exp Dermatol 1999;24:99-106.
6. Bamigbade TA, Langford RM. The clinical use of tramadol hydrochloride. Pain Rev 1998;5:155-82.
7. Sunshine A, Olson NZ, Zighelboim I, DeCastro A, Minn FL. Analgesic oral efficacy of tramadol hydrochloride in postoperative pain. Clin Pharmacol Ther 1992;51:740-6.
8. Reig E. Tramadol in musculoskeletal pain - A survey. Clin Rheumatol 2002;21(Suppl 1):S9-12.
9. Desmeules JA. The tramadol option. Eur J Pain 2000;4(Suppl A): 15-21.
10. Shipton EA. Tramadol - Present and future. Anaesth Intensive Care 2000;28:363-74.
11. Rose JB, Finkel JC, Arquedas-Mohs A, Himelstein BP, Schreiner M, Medve RA. Oral tramadol for the treatment of pain of 7-30 days' duration in children. Anesth Analg 2003;96:78-81.